Publications

Voltage-gated sodium channels in cancer. The biology, explained for non-scientists.

Author: Andrew Jonathan Hillman (ORCID 0009-0001-5396-321X)
Published: , Zenodo. Also published in The Hillman Letter.
DOI: 10.5281/zenodo.23352272 (all versions); this version 10.5281/zenodo.23352273
License: CC BY 4.0

Many metastatic cancer cells express voltage-gated sodium channels at much higher levels than surrounding tissue, and the channels may help them migrate. Targeted Osmotic Lysis is an investigational approach that tries to exploit that difference with a cardiac glycoside and a pulsed electric field. It is not FDA approved for any indication. Published work is preclinical and early case reports.

Educational content only. It is not medical advice. Targeted Osmotic Lysis is investigational and is not FDA approved for any indication. Talk with your own oncology team about any treatment decision.

Abstract

Explains voltage-gated sodium channel biology in cancer cells for non-scientists. Describes Targeted Osmotic Lysis as an investigational approach that is not FDA approved for any indication.

Indexed in OpenAlex under author A5139488776.

What is the research on voltage-gated sodium channels in cancer and Targeted Osmotic Lysis?

What are voltage-gated sodium channels?

Why do metastatic cancer cells express more sodium channels?

What is Targeted Osmotic Lysis?

Is Targeted Osmotic Lysis FDA approved, and how do patients access investigational therapies?

Sources

All publications · Andrew J. Hillman · Andrew Hillman, Dallas on LinkedIn · Book a meeting